New Product Contribution
14%
+2pp YoY
New products contributed 14% of FY26 revenue, up from 12% in FY25, with absolute sales growing 33% to ~₹145 Cr.
PUNJABCHEMICALSANDCROPPR
Manufacturing
15 May 2026
Punjab Chemicals and Crop Protection Limited — Q4 FY26
Punjab Chemicals delivered a resilient FY26 with record revenue of ₹1,029.8 Cr (+14.4% YoY) and PAT of ₹64 Cr (+64.3% YoY), driven by stable volumes, new product contributions (14% of sales, growing 16% YoY), and improved capacity utilization (agrochemicals...
Financial stats pending filing verification
2-Minute Summary
✦ AI-Generated from Full Transcript
Punjab Chemicals delivered a resilient FY26 with record revenue of ₹1,029.8 Cr (+14.4% YoY) and PAT of ₹64 Cr (+64.3% YoY), driven by stable volumes, new product contributions (14% of sales, growing 16% YoY), and improved capacity utilization (agrochemicals at 81%, industrial chemicals at 90%). Q4 saw gross margins expand 580bps YoY to 49.4% due to inventory build for the upcoming season, though EBITDA margin improved only modestly to 13.2% (+60bps). Management reiterated 15-20% revenue growth guidance for FY27, underpinned by new product ramp-up and three MoUs slated for commercialization. EBITDA margin target of 15% in 2-3 years remains intact. Key risk: further escalation in raw material costs from geopolitical tensions could pressure margins if price pass-through becomes difficult.
Key Numbers
Agrochemical Capacity Utilization
81%
+5pp YoY
Agrochemical division operated at 81% capacity utilization in Q4 FY26, reflecting improved operational efficiencies.
Industrial Chemical Capacity Utilization
90%
flat YoY
Industrial chemicals continued at ~90% utilization; management expects to double this segment's revenue in two years via exports to Southeast Asia.
CDMO Contribution
24-26%
+2pp YoY
CDMO business contributed 24-26% of FY26 revenue; new products expected to add ₹150-200 Cr in next two years.
Management Guidance
Revenue growth of 15-20% in FY27
Management reaffirmed 15-20% YoY revenue growth guidance for FY27, driven by new product ramp-up and steady demand for existing products.
Management guidance revenueEBITDA margin target of 15% in 2-3 years
Management targets improving EBITDA margin from ~12% to 15% over the next 2-3 years through product mix improvement and cost optimization.
Management guidance marginsCapex of ₹105-130 Cr in FY27
Planned capex includes ₹25-30 Cr maintenance, ₹20 Cr debottlenecking/compliance, and ₹60-80 Cr for a new production block.
Management guidance capexGreenfield site announcement by Q2/Q3 FY27
Management expects to finalize a greenfield land parcel and announce it within Q2 or Q3 of FY27.
Management guidance expansionKey Risks
Geopolitical supply chain disruptions
Rising raw material and logistics costs due to geopolitical tensions could pressure margins if price pass-through becomes difficult.
high · management_commentaryCustomer resistance to further price increases
Management noted that while recent price hikes have been accepted, further increases may face customer resistance, potentially impacting volumes.
medium · analyst_questionExecution risk in new product commercialization
Three MoUs slated for FY27 commercialization may face delays of a few months due to customer trials or geopolitical issues.
medium · analyst_questionGreenfield site acquisition delays
Previous attempts to acquire land fell through due to legal issues; further delays could constrain growth beyond FY28-29.
medium · analyst_questionNotable Quotes
We are now moving from consolidation phase over the last 2-3 years to growth phase with our efforts to bring in new products have started yielding dividends.
Unless and until this geopolitical situation suddenly creates a havoc where the raw materials are not available or some other things happen, we continue to hold our guidance of 15 to 20% year-on-year growth.
So far customer has accepted the price increase... but if this increase becomes significantly higher than what it has been so far then we'll have to see overall how does the market react to it.
Frequently Asked Questions
What was Punjab Chemicals and's revenue in Q4 FY26?
Punjab Chemicals and reported revenue of ₹1,030 Cr in Q4 FY26, representing a +14.4% change compared to the same quarter last year.
What guidance did Punjab Chemicals and management give for FY27?
Revenue growth of 15-20% in FY27: Management reaffirmed 15-20% YoY revenue growth guidance for FY27, driven by new product ramp-up and steady demand for existing products. EBITDA margin target of 15% in 2-3 years: Management targets improving EBITDA margin from ~12% to 15% over the next 2-3 years through product mix improvement and cost optimization. Capex of ₹105-130 Cr in FY27: Planned capex includes ₹25-30 Cr maintenance, ₹20 Cr debottlenecking/compliance, and ₹60-80 Cr for a new production block. Greenfield site announcement by Q2/Q3 FY27: Management expects to finalize a greenfield land parcel and announce it within Q2 or Q3 of FY27.
What are the key risks for Punjab Chemicals and in FY27?
Key risks include Geopolitical supply chain disruptions — Rising raw material and logistics costs due to geopolitical tensions could pressure margins if price pass-through becomes difficult.; Customer resistance to further price increases — Management noted that while recent price hikes have been accepted, further increases may face customer resistance, potentially impacting volumes.; Execution risk in new product commercialization — Three MoUs slated for FY27 commercialization may face delays of a few months due to customer trials or geopolitical issues.; Greenfield site acquisition delays — Previous attempts to acquire land fell through due to legal issues; further delays could constrain growth beyond FY28-29..
Did Punjab Chemicals and meet its previous quarter's guidance?
Scorecard data is being built as historical quarters are processed.
Where can I read the full Punjab Chemicals and Q4 FY26 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.